- Austria / Österreich
- Bosnia and Herzegovina / Босна и Херцеговина
- Bulgaria / България
- Croatia / Hrvatska
- Czech Republic & Slovakia / Česká republika & Slovensko
- France / France
- Germany / Deutschland
- Greece / ΕΛΛΑΔΑ
- Italy / Italia
- Netherlands / Nederland
- Nordic / Nordic
- Poland / Polska
- Portugal / Portugal
- Romania & Moldova / România & Moldova
- Slovenia / Slovenija
- Serbia & Montenegro / Србија и Црна Гора
- Spain / España
- Switzerland / Schweiz
- Turkey / Türkiye
- UK & Ireland / UK & Ireland
Now available in more than 3,000 orthodontic locations in North America, AcceleDent is being integrated into orthodontic practices in the United States and internationally as standard of care for accelerated orthodontic treatment. AcceleDent is an FDA-cleared, Class II medical device that speeds up orthodontic treatment by as much as 50 percent and relieves pain often associated with treatment.
Patients simply bite down on AcceleDent’s gently pulsating mouthpiece for 20 minutes daily, and the hands-free, noninvasive device employs patented SoftPulse Technology that accelerates bone remodeling and tooth movement at the cellular level.
Many respected orthodontists, including Dr. Sam Daher, Dr. Sonia Palleck, Dr. Jay Bowman and Dr. John Graham, choose AcceleDent as the preferred accelerated treatment modality because it has been clinically proven to address the two most common barriers to treatment: length of treatment and discomfort.
Manufactured by OrthoAccel Technologies, AcceleDent’s rapid adoption by orthodontists is credited to both a growing body of clinical evidence supporting the device’s safety and effectiveness, as well as high patient satisfaction among AcceleDent users.
In September 2015, a peer-reviewed article published in Angle Orthodontist titled “Pain Control in Orthodontics Using a Micropulse Vibration Device: A Randomized Clinical Trial” reported that micropulse vibration, as used in AcceleDent, significantly lowers biting pain and overall pain during orthodontic treatment.
Orthodontists such as Dr. Katie Graber, who practices in Illinois, say the reduction in discomfort is a huge benefit of treating patients with AcceleDent.
“This study clearly demonstrates that, in addition to faster tooth movement, AcceleDent provides ‘pure’ pain management for orthodontic patients who frequently report discomfort during treatment,” Graber said. “I’ve found that patients and parents appreciate AcceleDent’s reduction in discomfort because it eliminates the need for over-the-counter or prescription pain medication.”
Another clinical trial appeared in the September 2015 issue of Seminars in Orthodontics, and the results revealed that pulsatile forces, which AcceleDent employs, significantly accelerate tooth movement. This prospective, double-blind, randomized, controlled trial, demonstrates that gentle, non-invasive vibration increases the rate of tooth movement.
This scientific evidence reinforces the clinical results that AcceleDent providers have been achieving with this medical device for the past several years. The evidence is underscored by consistently positive patient reviews. In an independent survey, 100 percent of patients surveyed report they are satisfied with their experience using AcceleDent.
“The strong support from orthodontists and consumers is how we know that AcceleDent is such a game changer for the orthodontic industry,” said Michael K. Lowe, president and CEO of OrthoAccel. “Orthodontists understand the science that makes AcceleDent work, and patients are eager to receive the benefits of accelerated orthodontic treatment with AcceleDent.”
OrthoAccel captured No. 69 on the 2015 Deloitte Fast 500 ranking of the fastest growing technology companies in North America. Among the top 100 companies ranked on the prestigious list are some of this era’s most dynamic and respected technology brands such as Tesla, Fitbit and Twitter.
“The fact that OrthoAccel is the only orthodontic company ranked on the 2015 Deloitte Fast 500 shows the wealth of industry experience that our team has,” Lowe said. “As an innovation company, we remain laser-focused on revolutionizing the orthodontic industry by enhancing the patient treatment experience.”
(Source: OrthoAccel Technologies)
Mon. 7 October 2024
11:00 AM EST (New York)
Balancing Expansion, Extraction, and IPR for Optimal Outcomes
Mon. 7 October 2024
12:30 PM EST (New York)
SIMPLIFIED APPROACH TO ENDODONTIC INSTRUMENTATION AND OBTURATION
Mon. 7 October 2024
12:30 PM EST (New York)
Chairsideleistungen: Verschenken Sie kein Geld!
Tue. 8 October 2024
12:00 PM EST (New York)
(NEU)Integration eines Intraoral-Scanners - Tipps zur Abrechnung
Tue. 8 October 2024
7:00 PM EST (New York)
ITI US section live treatment planning session
Wed. 9 October 2024
8:00 PM EST (New York)
Optimizing Cementation Techniques for Indirect Restorations
Thu. 10 October 2024
9:00 AM EST (New York)
To post a reply please login or register